The EPA and DHA market includes products derived from marine sources containing omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA and DHA play an important role in brain and eye development in infants as well as protecting cardiovascular health in adults. They help reduce inflammation and lower risks of stroke, coronary heart disease, depression, and cognitive decline. Increasing awareness about health benefits of EPA and DHA has boosted demand for functional foods and beverages fortified with these fatty acids. The global EPA and DHA market is estimated to be valued at US$ 2135.1 Mn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the EPA and DHA market are KHS GmbH, Tetra Pak International SA (Tetra Laval Group), Syntegon Technology GmbH, JBT Corporation, GEA Group Aktiengesellschaft, Sidel Group (Tetra Laval Group), Krones AG, Ronchi Mario SPA, Coesia Group, and Barry-Wehmiller Companies Inc. These players are focusing on new product launches and innovations to meet the rising demand.

The growing demand for Global EPA And DHA Market Size supplements can be attributed to increasing health consciousness among consumers and shifting preference towards preventive healthcare. The increasing cases of lifestyle diseases and cardiometabolic disorders are prompting people to include EPA and DHA in their diets for obtaining associated health benefits.

Technological advancements are helping players improve the production and purification processes of EPA and DHA. Companies are investing in R&D to develop new techniques to extract these fatty acids from algae on a commercial scale and with higher yields. Algal DHA and EPA are likely to gain traction and meet the rising demand.

Market Trends

High oxidative stability of EPA and DHA makes them suitable for usage in various food processing techniques involving heat and other treatments. This is driving innovations in snacks and bakery products fortified with EPA and DHA. Furthermore, miniaturization of encapsulation technology is allowing manufacturers to offer EPA and DHA in smaller capsule sizes.

The growing vegan population is prompting companies to develop plant-based sources of EPA and DHA. Companies are exploring new sources of omega-3 such as certain microalgae to obtain EPA and DHA without involving marine sources. This is expected to provide new opportunities over the forecast period.

Market Opportunities

Innovations in microencapsulation techniques are enabling stable delivery of EPA and DHA in various delivery forms. This will support development of EPA and DHA fortified products across diverse categories like infant formula, dairy, confectionery etc.

Rising investments towards algal DHA and EPA commercialization present significant growth prospects. Low-cost commercial production of algal EPA and DHA at scale can help meet the massive global demand.

Get More Insights On This Topic: https://medicalinfoblogs.weebly.com/blog/the-epa-and-dha-market-set-to-grow-at-highest-pace-owing-to-rising-health-consciousness